Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-05

Clinical Trial Update: Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy study of ramelteon in adults with chronic insomnia has completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROZEREM (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Sleep Initiation and Maintenance Disorders | Phase 3 | Status: COMPLETED | Results posted: 2009-11-05